Delivery Order SPE2DB20D3103-SPE2DB23FN8A5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,714.84 delivery order is for the supply of Clonidine 0.3 mg/day patches. The contract has a firm fixed price and was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,193.00 firm fixed-price delivery order is for the supply of the medication Clonidine 0.3 mg/day patch. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,010.21 firm fixed-price delivery order is for the supply of the medication Clonidine 0.2 mg/day patches. The contract has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of CLONIDINE HCL ER 0.1 MG TABLET 60S, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,048.26 and an ultimate completion date of May 3, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,947.80 Delivery Order is for the supply of Clonidine Hydrochloride Extended-Release 0.1 mg tablets in 60-count bottles. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,006.82 firm fixed price delivery order is for the supply of Clonidine Hydrochloride Extended Release 0.17 mg Tablets in 30-count packages. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,956,820 units of Clonidine HCl ER 0.1 mg tablets in 60-count packages. The $2,018.04 contract has a performance period through March 14, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,900.30 firm fixed-price delivery order is for the supply of 4562815802 - Clonidine HCL ER 0.1 mg Tablets in 60-count packages. The contract has an ultimate completion date of November 15, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,085.27 firm-fixed-price delivery order is for the supply of 60-count clonidine hydrochloride extended-release 0.1 mg tablets. The contract has an ultimate completion date of January 4, 2024 and was awarded on January 3, 2024. No set-aside designation was used for this procurement. Amerisourcebergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,640.85, is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a firm fixed-price delivery order with a performance period ending on December 15, 2023. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN8A5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) valued at $1,826.40. The contract is with the Defense Logistics Agency (DLA) to provide 4,561,327,704 units of the medication Clonidine 0.2 mg/day patch. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a critical supplier of essential medical commodities to the Department of Defense and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/23/23 |